MYI DIAGNOSTICS

MYI Diagnostics is a biomedical research company that specializes in multiplexed proteomic profiling for precision medicine. MYI Diagnostics conducts confidential research in order to replace many of the targeted diagnostics for individual cancers, infectious diseases, metabolic conditions, and other rare or common disorders. The company also generates actionable individualized information to streamline clinical intervention strategies. MYI Diagnostics was founded by, Nicholas J. Schork, Devon Cayer, and Kristopher L. Nazor in 2015. The company is based in San Diego, California.